tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily

Coherus Biosciences (CHRS) Cash flow

1,397 Followers

Coherus Biosciences Cash Flow

CHRS's free cash flow for Q3 2024 was $-62.02M. For the 2024 fiscal year, CHRS's free cash flow was decreased by $68.84M and operating cash flow was $-62.02M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -61.98M$ -174.88M$ -241.12M$ -37.43M$ 154.15M$ 28.36M
Investing Cash Flow
$ 266.07M$ 144.64M$ -166.85M$ -138.41M$ -14.40M$ -12.73M
Financing Cash Flow
$ -186.84M$ 69.60M$ 54.33M$ 51.88M$ 223.95M$ 89.37M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 525.51M$ 63.99M$ 63.99M$ 417.63M$ 541.60M$ 177.91M
Income Tax Paid Supplemental Data
$ -118.00K$ -118.00K$ 40.00K$ 1.22M$ 3.95M$ 1.73M
Interest Paid Supplemental Data
$ 37.86M$ 37.86M$ 34.88M$ 18.68M$ 16.96M$ 15.26M
Issuance Of Capital Stock
$ 1.16M$ 1.81M$ 2.32M$ 43.91M$ 3.80M$ 3.52M
Issuance Of Debt
$ -223.41M-$ 49.93M$ -672.00K$ 221.77M$ 72.95M
Repayment Of Debt
$ -260.39M-$ -190.75M$ -672.00K$ -389.00K-
Free Cash Flow
$ 125.80M$ -174.32M$ -243.16M$ -38.72M$ 147.09M$ 26.53M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Coherus Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis